Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Initiation of Biphasic Insulin Aspart 30 Treatment in Subjects With Type 2 Diabetes Mellitus Failing OAD Therapy

NCT00605111 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT00605111
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00605111 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Initiation of Biphasic Insulin Aspart 30 Treatment in Subjects With Type 2 Diabetes Mellitus Failing OAD Therapy
Lead sponsor
Novo Nordisk A/S
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2003
Completion date
October 31, 2004
Enrollment
193 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2